Advisors to FCF

Dr. John Craig and Dr. Lola Reid are the lead medical/scientific advisors for FCF. In addition, listed below are leading physicians, scientists and researchers who deal with fibrolamellar hepatocellular carcinoma and have agreed to be advisors to FCF. Each represents an institution or laboratory which is currently involved in research or treatment of fibrolamellar liver cancer. It is from this group of advisors, under the guidance of Dr. Craig and Dr. Reid, that FCF puts together committees to review requests for grants.

 

Ghassan Abou-Alfa, M.D.

Attending Physician
Department of Medicine and Gastrointestinal Oncology Service
Memorial Sloan-Kettering Cancer Center, New York, NY

 

Nabeel Bardeesy, Ph.D.

Associate Professor of Medicine, Harvard Medical School
Massachusetts General Hospital Cancer Center
Boston, MA

 

Kevin C. Barry, Ph.D.

Postdoctoral Scholar
Department of Pathology
University of California, San Francisco

 

Michael Choti, M.D., M.B.A.

Professor and Chairman
Department of Surgery
UT Southwestern Medical Center, Dallas, Texas

 

John Craig, M.D. , PhD
Pathologist, Director of FCF
Carmel, California

 

Ronald P. DeMatteo, M.D., FACS

Chair, Department of Surgery at Penn Medicine
Head, Division of General Surgical Oncology

Penn Medicine, Philadelphia, PA

 

Anna Mae Diehl, M.D.

Professor
Department of Medicine
Duke University, North Carolina

 

Ephraim Fuchs, M.D.

Professor of Oncology and Immunology
Johns Hopkins University
Baltimore, MD

 

John Gordon, M.D., Ph.D.

Clinical Instructor, Oncology
GI Oncology Group and Shokat Laboratory
University of California, San Francisco

 

Tim Greten, M.D.

Senior Investigator
Thoracic and Gastrointestinal Oncology Branch
National Cancer Institute
Washington, DC

 

Yi Guo, Ph.D.

Associate Consultant and Assistant Professor
Biochemistry and Molecular Biology
Mayo Clinic, Rochester MN

 

Cynthia D. Guy, M.D.

Associate Professor
Department of Pathology
Duke University, North Carolina

 

William Harris, M.D.

Associate Professor
Division of Oncology
University of Washington School of Medicine
Seattle, WA

 

Ahmed Kaseb, M.D.

Director of Hepatocellular Carcinoma Program
Department of Gastrointestinal Medical Oncology
University of Texas M.D. Anderson Cancer Center

 

Amy K. Kim, M.D.

Associate Professor of Medicine
Division of Gastroenterology/Hepatology
Johns Hopkins University
Baltimore, MD

 

Olga Kozyreva, M.D.

Hematology/Oncology
Dana-Farber Cancer Institute
Boston, MA

 

Michael P. LaQuaglia, M.D., FACS, FRCS

Chief, Pediatric Surgical Service
Memorial Sloan-Kettering Cancer Center, New York

 

Ron Levine, M.D.

Internist
Greenwich, Connecticut

 

Barbara Lyons, Ph.D.

Associate Professor
Department of Chemistry and Biochemistry
New Mexico State University
Las Cruces, NM

 

Mark McNiven, Ph.D.

George M. Eisenberg Professor
Biochemistry and Molecular Biology
Mayo Clinic, Rochester Minnesota

 

Sofia de Oliveira, Ph.D.

EMBO Postdoctoral Fellow
Department of Medical Microbiology and Immunology
University of Wisconsin-Madison, Wisconsin

 

Hibba tul Rehman, M.D.

Chief Fellow
Division of Hematology/Oncology
University of Vermont, Burlington

 

Lola Reid, Ph.D.

Professor
Department of Cell and Molecular Physiology
University of North Carolina, Chapel Hill, North Carolina

 

 Julien Sage, Ph.D.

Associate Professor
Pediatrics (Hematology/Oncology) and of Genetics
Stanford University, California

 

Praveen Sethupathy, Ph.D.

Associate Professor
Department of Biomedical Sciences
Cornell University College of Veterinary Medicine
Ithaca, NY

 

Kevin M. Sullivan, M.D.

R3/General Surgery
University of Washington
Seattle, WA

 

Michael Torbenson, M.D.

Senior Associate Consultant
Department of Anatomic Pathology
Mayo Clinic, Rochester, Minnesota

 

Jean-Nicholas Vauthey, M.D.

Professor
Department of Surgical Oncology
University of Texas MD Anderson Cancer Center
Houston, TX

 

Alan P. Venook, M.D.

Professor
Department of Medicine (Hematology/Oncology)
University of California, San Francisco

 

Yuzhuo Wang, Ph.D.

University of British Columbia Cancer Center
Vancouver